Breaking News
0
Ad-Free Version. Subscribe now to follow markets, faster and distraction-free. More details
Close

Glaxosmith (GLAXOSM)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
7.00 0.00    0.00%
22/01 - Closed. Currency in NGN ( Disclaimer )
Type:  Equity
Market:  Nigeria
ISIN:  NGGLAXOSMTH8 
  • Volume: 2,855,083
  • Bid/Ask: 6.95 / 7.20
  • Day's Range: 7.00 - 7.00
Glaxosmith 7.00 0.00 0.00%
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close7
Day's Range7 - 7
Revenue26.28B
Open7
52 wk Range0 - 24.8
EPS0.41
Volume2,855,083
Market Cap8.37B
Dividend (Yield)0.55 (9.57%)
Average Volume (3m)2,547,162
P/E Ratio49.66
Beta0.67
1-Year Change16.67%
Shares Outstanding1,195,876,000
Next Earnings DateMar 03, 2021
What is your sentiment on Glaxosmith?
or
Market is currently closed. Voting is open during market hours.

Glaxosmith News


Technical Summary

Type 5 Min 15 Min Hourly Daily Monthly
Moving Averages Strong Sell Strong Sell Sell Buy Sell
Technical Indicators Sell Strong Sell Strong Sell BUY Strong Buy
Summary Strong Sell Strong Sell Strong Sell Buy Neutral

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Bullish Engulfing 5H Current
Completed Patterns
Gravestone Doji 1W 1 Jan 10, 2021
Engulfing Bearish 1D 1 Jan 21, 2021
Three Outside Down 5H 1 Jan 21, 2021 14:00

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  Notore Chemical Industries 56.25 56.25 56.25 0.00 0.00% 0 19/01  
  Guaranty Trust Bank 33.10 33.15 33.00 +0.10 +0.30% 20.52M 22/01  
  Firstcity Bnk 3.170 3.290 3.250 +0.100 +3.17% 2.22M 22/01  
  11 225.20 225.20 225.20 -24.30 -9.74% 15.30K 22/01  
  UBN 5.60 5.55 5.55 +0.10 +1.83% 790.46K 22/01  
  Guinea Insurance PLC 0.21 0.22 0.21 -0.01 -4.55% 569.02K 22/01  
  Aiico 1.30 1.32 1.30 -0.14 -9.72% 2.92M 22/01  
  Abctrans 0.36 0.36 0.36 0.00 0.00% 31.06K 22/01  
  Access Bank 9.15 9.35 9.15 -0.10 -1.08% 18.70M 22/01  
  Cadbury Nig 9.75 9.75 9.75 0.00 0.00% 433.69K 22/01  

Glaxosmith Company Profile

IndustryBiotechnology & Drugs
SectorHealthcare
Employees

131

Equity Type

ORD

GlaxoSmithKline Consumer Nigeria Plc is a Nigeria-based research-based pharmaceutical and healthcare company. The principal activities of the Company are manufacturing, marketing and distribution of consumer healthcare and pharmaceutical products. The Company's operating segments include Pharmaceuticals and Consumer Healthcare. The Consumer Healthcare segment includes oral care, over-the-counter (OTC) medicines and nutritional healthcare. The Pharmaceuticals segment consists of antibacteria, vaccines and prescription drugs. The Company offers Consumer Healthcare brands, such as Panadol, Andrews Liver Salt, Macleans, Otrivin, Sensodyne, Voltaren and a range of pharmaceuticals, including Ampiclox, Amoxil, Augmentin, Zentel, Halfan and vaccines. Global Manufacturing and Supply (GMS) is the manufacturing unit of the Company located in Agbara, Ogun State.

Read More
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

GLAXOSM Comments

Write your thoughts about Glaxosmith
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email